Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29,881,634
-
Total 13F shares
-
9,406,781
-
Share change
-
-103,507
-
Total reported value
-
$74,869,184
-
Put/Call ratio
-
417%
-
Price per share
-
$7.96
-
Number of holders
-
42
-
Value change
-
-$1,117,695
-
Number of buys
-
20
-
Number of sells
-
12
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q3 2024
As of 30 Sep 2024,
Profound Medical Corp. - Common Shares (PROF) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,406,781 shares.
The largest 10 holders included
FIL Ltd, GAGNON SECURITIES LLC, LETKO, BROSSEAU & ASSOCIATES INC, Raymond James Financial Services Advisors, Inc., Timelo Investment Management Inc., Gagnon Advisors, LLC, ROYCE & ASSOCIATES LP, Rosalind Advisors, Inc., Royal Bank of Canada, and ARDSLEY ADVISORY PARTNERS LP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.